Topic

Vyndaqel / Vyndamax (tafamidis)

A collection of 27 issues

Renewing Vyndaqel/Vyndamax (Tafamidis) Approval with Aetna CVS Health in Illinois: Annual Requirements and Timeline

Answer Box: Renewing Your Tafamidis Approval in Illinois Aetna CVS Health requires annual reauthorization for tafamidis (Vyndaqel/Vyndamax), typically 30-60 days before your current approval expires. Start early: gather updated clinical documentation showing treatment response (echocardiogram, NT-proBNP levels, functional status). Submit renewal through your prescriber via Aetna's provider
5 min read

How Long Does It Take to Get Vyndaqel / Vyndamax (tafamidis) Approved by Humana in New York? Complete Timeline Guide

Quick Answer: Vyndaqel / Vyndamax Approval Timeline with Humana Standard approval: 30 days from complete submission. Expedited review: 72 hours if medically urgent. Key requirements: Confirmed ATTR-CM diagnosis (PYP scan or biopsy), NYHA Class I-III, cardiology oversight. Fastest path: Submit complete PA packet with diagnostic imaging, specialist letter, and prior therapy
5 min read

How to Get Vyndaqel/Vyndamax (Tafamidis) Covered by Aetna CVS Health in North Carolina: Complete Guide to Prior Authorization, Appeals, and External Review

Answer Box: Getting Tafamidis Covered by Aetna CVS Health in North Carolina Quick Path to Approval: Aetna requires prior authorization for both Vyndaqel and Vyndamax (tafamidis) with confirmed ATTR-CM diagnosis via PYP scan or biopsy, NYHA Class I-III symptoms, and specialist prescriber. First step today: Verify your 2025 formulary status—
6 min read